Exploring new near-infrared fluorescent disulfide-based cyclic RGD peptide analogs for potential integrin-targeted optical imaging

We synthesized disulfide-based cyclic RGD pentapeptides bearing a near-infrared fluorescent dye (cypate), represented by cypate- c(CRGDC) ( 1) for integrin-targeted optical imaging. These compounds were compared with the traditional lactam-based cyclic RGD counterpart, cypate- c(RGDfK) ( 2). Molecul...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry letters Vol. 21; no. 7; pp. 2116 - 2120
Main Authors Ye, Yunpeng, Xu, Baogang, Nikiforovich, Gregory V., Bloch, Sharon, Achilefu, Samuel
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Ltd 01.04.2011
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We synthesized disulfide-based cyclic RGD pentapeptides bearing a near-infrared fluorescent dye (cypate), represented by cypate- c(CRGDC) ( 1) for integrin-targeted optical imaging. These compounds were compared with the traditional lactam-based cyclic RGD counterpart, cypate- c(RGDfK) ( 2). Molecular modeling suggests that the binding affinity of 2 to integrin α vβ 3 is an order of magnitude higher than that of 1. This was confirmed experimentally, which further showed that substitution of Gly with Pro, Val and Tyr in 1 remarkably hampered the α vβ 3 binding. Interestingly, cell microscopy with A549 cells showed that 1 exhibited higher cellular staining than 2. These results indicate that factors other than receptor binding affinity to α vβ 3 dimeric proteins mediate cellular uptake. Consequently, 1 and its analogs may serve as valuable molecular probes for investigating the selectivity and specificity of integrin targeting by optical imaging.
Bibliography:http://dx.doi.org/10.1016/j.bmcl.2011.01.133
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Present address: MolLife Design LLC, St. Louis, MO, USA
ISSN:0960-894X
1464-3405
1464-3405
DOI:10.1016/j.bmcl.2011.01.133